Expression of NKG2D ligands is downregulated by beta-catenin signaling and associates with HCC aggressiveness
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expression of NKG2D ligands is downregulated by beta-catenin signaling and associates with HCC aggressiveness
Authors
Keywords
NKG2D ligands, hepatocellular carcinoma, HCC, β-catenin-signalling
Journal
JOURNAL OF HEPATOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-01-22
DOI
10.1016/j.jhep.2021.01.017
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune exclusion-Wnt/CTNNB1 class predicts resistance to immunotherapies in HCC
- (2019) Roser Pinyol et al. CLINICAL CANCER RESEARCH
- The role of telomeres and telomerase in cirrhosis and liver cancer
- (2019) Jean-Charles Nault et al. Nature Reviews Gastroenterology & Hepatology
- β-Catenin Activation Promotes Immune Escape and Resistance to Anti–PD-1 Therapy in Hepatocellular Carcinoma
- (2019) Marina Ruiz de Galarreta et al. Cancer Discovery
- The Immunobiology of Hepatocellular Carcinoma in Humans and Mice: Basic Concepts and Therapeutic Implications
- (2019) Jiajie Hou et al. JOURNAL OF HEPATOLOGY
- BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA
- (2019) Théo Z. Hirsch et al. JOURNAL OF HEPATOLOGY
- NKG2D and its ligands in cancer
- (2018) Payal Dhar et al. CURRENT OPINION IN IMMUNOLOGY
- Lect2 controls inflammatory monocytes to constrain the growth and progression of hepatocellular carcinoma
- (2018) Antoine L'Hermitte et al. HEPATOLOGY
- The Paradoxical Role of NKG2D in Cancer Immunity
- (2018) Sam Sheppard et al. Frontiers in Immunology
- Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress
- (2018) Quentin Bayard et al. Nature Communications
- Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis
- (2017) Daniela Sia et al. GASTROENTEROLOGY
- Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features
- (2017) Daniela Sia et al. GASTROENTEROLOGY
- Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification
- (2017) Julien Calderaro et al. JOURNAL OF HEPATOLOGY
- Liver cancer: Translating '–omics' results into precision medicine for hepatocellular carcinoma
- (2017) Daniela Sia et al. Nature Reviews Gastroenterology & Hepatology
- The immunoreceptor NKG2D promotes tumour growth in a model of hepatocellular carcinoma
- (2017) Sam Sheppard et al. Nature Communications
- Decreased expression of the NKG2D ligand ULBP4 may be an indicator of poor prognosis in patients with nasopharyngeal carcinoma
- (2017) Yuanji Xu et al. Oncotarget
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- Hepatocellular carcinoma
- (2016) Josep M. Llovet et al. Nature Reviews Disease Primers
- Genetic Landscape and Biomarkers of Hepatocellular Carcinoma
- (2015) Jessica Zucman-Rossi et al. GASTROENTEROLOGY
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- (2015) Stefani Spranger et al. NATURE
- Erratum: Advances in targeted therapies for hepatocellular carcinoma in the genomic era
- (2015) Josep M. Llovet et al. Nature Reviews Clinical Oncology
- MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer
- (2015) Hanbyoul Cho et al. BMC CANCER
- Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis
- (2014) Jean Charles Nault et al. HEPATOLOGY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Regulation of Ligands for the NKG2D Activating Receptor
- (2013) David H. Raulet et al. Annual Review of Immunology
- A Hepatocellular Carcinoma 5-Gene Score Associated With Survival of Patients After Liver Resection
- (2013) Jean–Charles Nault et al. GASTROENTEROLOGY
- Hepatocellular Benign Tumors—From Molecular Classification to Personalized Clinical Care
- (2013) Jean–Charles Nault et al. GASTROENTEROLOGY
- T-cell factor 4 and β-catenin chromatin occupancies pattern zonal liver metabolism in mice
- (2013) Angélique Gougelet et al. HEPATOLOGY
- Genetics of hepatocellular carcinoma: The next generation
- (2013) Jean-Charles Nault et al. JOURNAL OF HEPATOLOGY
- Effects of MICA Expression on the Prognosis of Advanced Non-Small Cell Lung Cancer and the Efficacy of CIK Therapy
- (2013) Yu Chen et al. PLoS One
- NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study
- (2012) Esther M de Kruijf et al. BMC CANCER
- Oncogenic β-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice
- (2012) Marie Anson et al. JOURNAL OF CLINICAL INVESTIGATION
- Hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hepatocellular Carcinoma
- (2011) Hashem B. El-Serag NEW ENGLAND JOURNAL OF MEDICINE
- Secretome-Based Identification of ULBP2 as a Novel Serum Marker for Pancreatic Cancer Detection
- (2011) Ya-Ting Chang et al. PLoS One
- ULBP2 and RAET1E NKG2D ligands are independent predictors of poor prognosis in ovarian cancer patients
- (2010) Roger W. McGilvray et al. INTERNATIONAL JOURNAL OF CANCER
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Differential Clinical Significance of Individual NKG2D Ligands in Melanoma: Soluble ULBP2 as an Indicator of Poor Prognosis Superior to S100B
- (2009) A. Paschen et al. CLINICAL CANCER RESEARCH
- NKG2D Ligand Expression in Human Colorectal Cancer Reveals Associations with Prognosis and Evidence for Immunoediting
- (2009) R. W. McGilvray et al. CLINICAL CANCER RESEARCH
- Two-dimensional differential gel electrophoresis/analysis of diethylnitrosamine induced rat hepatocellular carcinoma
- (2008) Yanting Qi et al. INTERNATIONAL JOURNAL OF CANCER
- Up on the tightrope: natural killer cell activation and inhibition
- (2008) Lewis L Lanier NATURE IMMUNOLOGY
- Recurrence of Hepatocellular Carcinoma
- (2008) Morris Sherman NEW ENGLAND JOURNAL OF MEDICINE
- Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
- (2008) Yujin Hoshida et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started